Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 3
2005 3
2007 2
2009 3
2010 2
2011 2
2012 3
2013 5
2014 1
2016 1
2017 1
2019 3
2020 4
2021 1
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
IFNγ binding to extracellular matrix prevents fatal systemic toxicity.
Kemna J, Gout E, Daniau L, Lao J, Weißert K, Ammann S, Kühn R, Richter M, Molenda C, Sporbert A, Zocholl D, Klopfleisch R, Lortat-Jacob H, Aichele P, Kammertoens T, Blankenstein T. Kemna J, et al. Among authors: kammertoens t. Nat Immunol. 2023 Mar;24(3):414-422. doi: 10.1038/s41590-023-01420-5. Epub 2023 Feb 2. Nat Immunol. 2023. PMID: 36732425 Free PMC article.
IFN-γ-dependent tumor-antigen cross-presentation by lymphatic endothelial cells promotes their killing by T cells and inhibits metastasis.
Garnier L, Pick R, Montorfani J, Sun M, Brighouse D, Liaudet N, Kammertoens T, Blankenstein T, Page N, Bernier-Latamani J, Tran NL, Petrova TV, Merkler D, Scheiermann C, Hugues S. Garnier L, et al. Among authors: kammertoens t. Sci Adv. 2022 Jun 10;8(23):eabl5162. doi: 10.1126/sciadv.abl5162. Epub 2022 Jun 8. Sci Adv. 2022. PMID: 35675399 Free PMC article.
Immunotherapy: target the stroma to hit the tumor.
Kammertoens T, Schüler T, Blankenstein T. Kammertoens T, et al. Trends Mol Med. 2005 May;11(5):225-31. doi: 10.1016/j.molmed.2005.03.002. Trends Mol Med. 2005. PMID: 15882610 Review.
It's the peptide-MHC affinity, stupid.
Kammertoens T, Blankenstein T. Kammertoens T, et al. Cancer Cell. 2013 Apr 15;23(4):429-31. doi: 10.1016/j.ccr.2013.04.004. Cancer Cell. 2013. PMID: 23597560 Free article.
High Salt Inhibits Tumor Growth by Enhancing Anti-tumor Immunity.
Willebrand R, Hamad I, Van Zeebroeck L, Kiss M, Bruderek K, Geuzens A, Swinnen D, Côrte-Real BF, Markó L, Lebegge E, Laoui D, Kemna J, Kammertoens T, Brandau S, Van Ginderachter JA, Kleinewietfeld M. Willebrand R, et al. Among authors: kammertoens t. Front Immunol. 2019 Jun 4;10:1141. doi: 10.3389/fimmu.2019.01141. eCollection 2019. Front Immunol. 2019. PMID: 31214164 Free PMC article.
Targeting c-MYC with T-cells.
Helm F, Kammertoens T, Lehmann FM, Wilke A, Bruns H, Mautner J, Bornkamm GW, Gerbitz A. Helm F, et al. Among authors: kammertoens t. PLoS One. 2013 Oct 10;8(10):e77375. doi: 10.1371/journal.pone.0077375. eCollection 2013. PLoS One. 2013. PMID: 24130880 Free PMC article.
Publisher Correction: IFNγ binding to extracellular matrix prevents fatal systemic toxicity.
Kemna J, Gout E, Daniau L, Lao J, Weißert K, Ammann S, Kühn R, Richter M, Molenda C, Sporbert A, Zocholl D, Klopfleisch R, Lortat-Jacob H, Aichele P, Kammertoens T, Blankenstein T. Kemna J, et al. Among authors: kammertoens t. Nat Immunol. 2023 Mar;24(3):558. doi: 10.1038/s41590-023-01464-7. Nat Immunol. 2023. PMID: 36813983 Free PMC article. No abstract available.
Tumour ischaemia by interferon-γ resembles physiological blood vessel regression.
Kammertoens T, Friese C, Arina A, Idel C, Briesemeister D, Rothe M, Ivanov A, Szymborska A, Patone G, Kunz S, Sommermeyer D, Engels B, Leisegang M, Textor A, Fehling HJ, Fruttiger M, Lohoff M, Herrmann A, Yu H, Weichselbaum R, Uckert W, Hübner N, Gerhardt H, Beule D, Schreiber H, Blankenstein T. Kammertoens T, et al. Nature. 2017 May 4;545(7652):98-102. doi: 10.1038/nature22311. Epub 2017 Apr 26. Nature. 2017. PMID: 28445461 Free PMC article.
36 results